Genomic Health Posts 8 Percent Increase in Q4 Revenues | GenomeWeb

NEW YORK (GenomeWeb) ─ Genomic Health reported after the close of the market Wednesday that its fourth quarter revenues rose 8 percent year over year as the firm reported a 12 percent increase in Oncotype DX test results delivered during the quarter.

For the three months ended Dec. 31, Genomic Health's product revenues rose to $74.5 million from $69.1 million in the same period last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.